Objective To investigate the correlation between serum plasma membrane vesicle-associated protein (PLVAP) levels and metabolism-associated fatty liver disease (MAFLD) in patients with T2DM. Methods Atotal of 255 patients with type 2 diabetes mellitus (T2DM) went to Gansu Provincial Hospital from September 2023 to March 2024 were selected in this study,and were divided into T2DM alone group (n=141) and the T2DM combined with MAFLD group (n=114) according to whether they were combined with MAFLD or not.Spearman correlation analysis was used to analyze the correlation between serum PLVAP and other indexes,multiple linear regression analysis was used to analyze the influencing factors of serum PLVAP,and Logistic regression analysis was used to analyze the influencing factors of MAFLD in T2DM patients. The early diagnostic value of serum PLVAP on MAFLD in patients with T2DM by analyzing the receiver's operating characteristics (ROC) curve. Results Compared with the MAFLD group,BMI,WC,FPG,C-P,HOMA-IR,TG,AST,ALT,GGT,hepatic steatosis index (HSI) and phytohaemagglutinin-like oxidized low-density lipoprotein receptor 1 (LOX-1) were decreased in the T2DM group (P<0.05).DM duration,HDL-C,AST/ALT and PLVAP were elevated (P<0.05). Spearman correlation analysis showed that PLVAP was positively correlated with AST/ALT (P<0.05) and negatively correlated with WC,DBP,C-P,ALT,GGT and HSI (P<0.05). Multiple linear regression analysis showed that WC was an influencing factor for PLVAP.Logistic regression analysis showed that DM duration,WC,TG,PLVAP,LOX-1 were influencing factors for MAFLD. Analysis of the subjects' work characteristics (ROC) curve showed that the area under the ROC curve was 0.785,with a sensitivity of 81.6％ and a specificity of 67.4％. Conclusions Reduced PLVAP is a risk factor for comorbid MAFLD in patients with T2DM and is important for predicting the co-existence of MAFLD in patients with T2DM.

Objective To investigate the correlation between serum plasma membrane vesicle-associated protein (PLVAP) levels and metabolism-associated fatty liver disease (MAFLD) in patients with T2DM. Methods Atotal of 255 patients with type 2 diabetes mellitus (T2DM) went to Gansu Provincial Hospital from September 2023 to March 2024 were selected in this study,and were divided into T2DM alone group (n=141) and the T2DM combined with MAFLD group (n=114) according to whether they were combined with MAFLD or not.Spearman correlation analysis was used to analyze the correlation between serum PLVAP and other indexes,multiple linear regression analysis was used to analyze the influencing factors of serum PLVAP,and Logistic regression analysis was used to analyze the influencing factors of MAFLD in T2DM patients. The early diagnostic value of serum PLVAP on MAFLD in patients with T2DM by analyzing the receiver's operating characteristics (ROC) curve. Results Compared with the MAFLD group,BMI,WC,FPG,C-P,HOMA-IR,TG,AST,ALT,GGT,hepatic steatosis index (HSI) and phytohaemagglutinin-like oxidized low-density lipoprotein receptor 1 (LOX-1) were decreased in the T2DM group (P<0.05).DM duration,HDL-C,AST/ALT and PLVAP were elevated (P<0.05). Spearman correlation analysis showed that PLVAP was positively correlated with AST/ALT (P<0.05) and negatively correlated with WC,DBP,C-P,ALT,GGT and HSI (P<0.05). Multiple linear regression analysis showed that WC was an influencing factor for PLVAP.Logistic regression analysis showed that DM duration,WC,TG,PLVAP,LOX-1 were influencing factors for MAFLD. Analysis of the subjects' work characteristics (ROC) curve showed that the area under the ROC curve was 0.785,with a sensitivity of 81.6％ and a specificity of 67.4％. Conclusions Reduced PLVAP is a risk factor for comorbid MAFLD in patients with T2DM and is important for predicting the co-existence of MAFLD in patients with T2DM.

Objective : To summarize experience treating dog bites in the oral and maxillofacial regions of children and provide a reference for clinical practice. Methods : Nineteen children with dog bite wounds in the maxillofacial region were treated from July 2011 to June 2018 with primary debridement and suturing. A rabies vaccine, tetanus vaccine and human immunoglobulin as a passive immune agent were given via intramuscular injection. Anti-inflammatory therapy with amoxicillin and clavulanate potassium or other antibiotics. Follow-up observation and a retrospective analysis of the treatment effect were carried out. Results: After treatment, among the 19 pediatric patients, 18 cases showed primary healing and 1 case showed secondary healing. The follow-up period ranged from six months to seven and a half years. No cases of rabies occurred. Conclusion For the treatment of patients with maxillofacial dog bite wounds, the first stage debridement and suture can reduce the scar after operation and is beneficial to the recovery of face.

Objective : To research the feasibility and preliminary clinical effect of an implant-supported fixed bridge based on interactions with the posterior interocclusal space deficiency. Methods: Four patients with multiple implant-supported fixed-bridge restorations for interocclusal space deficiency in posterior teeth were included in this study. The 8 total implant sites had an average interocclusal space size of 3.3 mm. Two abutments with an undercut area were performed, the fixed bridge was placed by rotating it without a common path of insertion, and the abutment screw was then tightened. In the production process, the interaction retention concept and methods were fully communicated to the technician. The abutments and bridges on the implants were placed, and the clinical effect was observed. Results: The prosthesis was fixed well and presented appropriate functioning. At the 3-month and 18-month follow-up examination, the prosthesis and abutments were not loose, and the abutments did not release or break. No swelling or tenderness was observed in the margin of the implants. Conclusion The interaction retention is a good method of resolving the problem of interocclusal space deficiencies in the posterior teeth.

OBJECTIVETo explore the expression of Notch signaling receptors Notchl, Notch3 and its ligand Jaggedl, Jagged2 in tongue squamous cell carcinoma (TSCC).

METHODSmRNA and protein expression levels of tissue samples from 74 cases of tongue cancer patients and human tongue cell line Cal-27 were detected by reverse transcriptase-polymerase chain reaction (RT-PCR), immunohistochemistry and Western blot. Its relationship with cell proliferation and clinical pathology was analyzed.

RESULTSmRNA and protein expression were detected in tongue cancer tissues, adjacent tissues and cell lines. Notchl and Notch3 protein expression in tongue cancer was higher than the adjacent tissues. Jaggedl and Jagged2 protein expression in tongue cancer and adjacent tissues had no difference. Notchl and Notch3 protein had correlation with tongue cancer clinical staging. Pathway protein expression had no correlation with pathological grade, age, gender. Notchl protein expression in lymph node metastasis-positive cases was higher than in lymph node metastasis-negative cases. The expression of Notch3 and Jagged2 had correlation. Jaggedl expression grade in metastasis-positive cases was higher than in negative cases.

CONCLUSIONNotch signaling molecules have active expression in TSCC and may play important roles in tongue cancer development.

Blotting, Western ; Carcinoma, Squamous Cell ; Cell Line ; Cell Proliferation ; Humans ; Immunohistochemistry ; Lymphatic Metastasis ; Neoplasm Staging ; RNA, Messenger ; Receptors, Notch ; Tongue ; Tongue Neoplasms

AIM: To investigate the effect and mechanisms of siRNA-hTERT-induced inhibition of Tca8113 tongue cancer cells in vitro and in vivo. METHODS: A small interference RNA (siRNA) targeting to hTERT mRNA (siRNA-hTERT_1) was constructed. The siRNA was transfected into Tca8113 tongue cancer cells in vivo and in vitro with cationic liposome. A non-specific siRNA (siRNA-hTERT_2) and non-treatment were used as negative control group and blank group. The cell growth in vitro was detected by MTT method. The cell apoptosis in vitro was analyzed by flow cytometry. The effect of siRNA-hTERT_1 on xenografts in nude mice was observed by determining the tumor size. The cell apoptosis in xenografts was analyzed by Hoechst staining. The expressions of hTERT mRNA in vitro and in vivo were detected by RT- PCR. RESULTS: The inhibition rates of cell growth in vitro 72 h after siRNA-hTERT_1 treatment was 47.2%, significantly higher than that in siRNA-hTERT_2 treatment group (2.6%, P<0.01). The cell apoptosis rate was 27.30%±0.18% in vitro, significantly increased at 48 h after transfection of siRNA-hTERT_1, compared to negative control group and blank group (P<0.01). The size of xenografts in siRNA-hTERT_1 treatment group was (298.8±138.7)mm~3, significantly smaller than that in siRNA-hTERT_2 treatment group and blank group (495.1±151.6)mm~3 and (506.8±207.4)mm~3, the inhibition rate was 40.0% (P<0.01). The numbers of apoptotic cells in xenografts significantly increased after transfection of siRNA-hTERT_1, compared to negative control group and blank group (P<0.01). Compared to negative control group and blank group, the expression of hTERT mRNA in Tca8113 tongue cancer cells in vitro and in vivo was inhibited by siRNA-hTERT_1. CONCLUSION: siRNA-hTERT_1 powerfully inhibits the growth of Tca8113 tongue cancer cells in vitro and in vivo. The specific inhibition of hTERT mRNA expression and cell apoptosis may be its main mechanisms.